Literature DB >> 2301990

Clinical monitoring of steatorrhoea in cystic fibrosis.

M P Walters1, J Kelleher, J Gilbert, J M Littlewood.   

Abstract

In 100 patients with cystic fibrosis the severity of steatorrhoea was assessed by three separate methods. Using chemical faecal fat assay as the gold standard, two other rapid and inexpensive methods were compared with it. The steatocrit method proved unreliable in our hands and gave little indication of the presence or severity of steatorrhoea. The more simple microscopy method was highly sensitive (97%) and only three of 80 patients with steatorrhoea were missed. All patients with severe steatorrhoea (greater than 60 mmol fat/day) were clearly demonstrated. The method is applicable to spot faecal samples and can readily be carried out on an outpatient basis. In centres where faecal fat assays are not available, the simple and cheap microscopic examination will give some indication of the response to enzyme treatment and may also help to identify non-compliant individuals.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2301990      PMCID: PMC1792391          DOI: 10.1136/adc.65.1.99

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  10 in total

1.  Microscopical examination of the stool for steatorrhea.

Authors:  G D DRUMMEY; J A BENSON; C M JONES
Journal:  N Engl J Med       Date:  1961-01-12       Impact factor: 91.245

2.  Sudan stain of fecal fat: new insight into an old test.

Authors:  M R Khouri; G Huang; Y F Shiau
Journal:  Gastroenterology       Date:  1989-02       Impact factor: 22.682

3.  Use of unabsorbed radioactive marker substances in a re-assessment of the radioactive triolein test of fat absorption.

Authors:  R K Ditchburn; A H Smith; C J Hayter
Journal:  J Clin Pathol       Date:  1971-09       Impact factor: 3.411

4.  Use of a standard fatty meal as a test for fat absorption.

Authors:  W A Penfold; W M Keynes
Journal:  Ann Surg       Date:  1971-01       Impact factor: 12.969

5.  The steatocrit.

Authors:  D D'Agostino; M Orsi
Journal:  J Pediatr Gastroenterol Nutr       Date:  1988 Nov-Dec       Impact factor: 2.839

6.  Markers for faecal fat estimation in monitoring steatorrhoea in cystic fibrosis.

Authors:  J Gilbert; J Kelleher; M P Walters; J M Littlewood
Journal:  Gut       Date:  1988-09       Impact factor: 23.059

7.  Assessment of fat malabsorption.

Authors:  L B Teh; M Stopard; S Anderson; A Grant; D Quantrill; R H Wilkinson; D P Jewell
Journal:  J Clin Pathol       Date:  1983-12       Impact factor: 3.411

8.  Stool microscopy in screening for steatorrhoea.

Authors:  S K Ghosh; J M Littlewood; D Goddard; A E Steel
Journal:  J Clin Pathol       Date:  1977-08       Impact factor: 3.411

9.  [14C]-triolein absorption: a useful test in the diagnosis of malabsorption.

Authors:  J M Turner; S Lawrence; I W Fellows; I Johnson; P G Hill; G K Holmes
Journal:  Gut       Date:  1987-06       Impact factor: 23.059

10.  The steatocrit: a simple method for monitoring fat malabsorption in patients with cystic fibrosis.

Authors:  C Colombo; R Maiavacca; M Ronchi; E Consalvo; M Amoretti; A Giunta
Journal:  J Pediatr Gastroenterol Nutr       Date:  1987 Nov-Dec       Impact factor: 2.839

  10 in total
  9 in total

Review 1.  Control of malabsorption in cystic fibrosis.

Authors:  J M Littlewood; S P Wolfe
Journal:  Paediatr Drugs       Date:  2000 May-Jun       Impact factor: 3.022

2.  Fat malabsorption in cystic fibrosis: comparison of quantitative fat assay and a novel assay using fecal lauric/behenic acid.

Authors:  Jill Dorsey; Donna Buckley; Suzanne Summer; Ronald J Jandacek; Therese Rider; Patrick Tso; Michael R Narkewicz; James E Heubi
Journal:  J Pediatr Gastroenterol Nutr       Date:  2010-04       Impact factor: 2.839

3.  Clinical monitoring of steatorrhoea in cystic fibrosis.

Authors:  G A Brown; I W Booth
Journal:  Arch Dis Child       Date:  1990-08       Impact factor: 3.791

4.  Using the steatocrit to determine optimal fat content in modular feeds.

Authors:  M O Rawashdeh; D R Lloyd; J W Puntis; G A Brown; I W Booth
Journal:  Arch Dis Child       Date:  1992-05       Impact factor: 3.791

5.  Improving care for central nervous system tumours: a mood for change.

Authors:  L S Lashford; D A Walker
Journal:  Arch Dis Child       Date:  1997-02       Impact factor: 3.791

Review 6.  Diagnosing cystic fibrosis: blood, sweat, and tears.

Authors:  C Wallis
Journal:  Arch Dis Child       Date:  1997-02       Impact factor: 3.791

Review 7.  Nutritional management of the infant with cystic fibrosis.

Authors:  M R Green; E Buchanan; L T Weaver
Journal:  Arch Dis Child       Date:  1995-05       Impact factor: 3.791

8.  Omeprazole, a proton pump inhibitor, improves residual steatorrhoea in cystic fibrosis patients treated with high dose pancreatic enzymes.

Authors:  Marijke Proesmans; Kris De Boeck
Journal:  Eur J Pediatr       Date:  2003-09-17       Impact factor: 3.183

Review 9.  Update on intestinal strictures.

Authors:  J M Littlewood
Journal:  J R Soc Med       Date:  1999       Impact factor: 18.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.